Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.
Rizzieri DA, Talbot JT, Long GD, Vredenburgh JJ, Gasparetto C, Smith CS, Colvin MO, Adams D, Morris A, Dodge R, Loftis J, Waters-Pick B, Reese M, Carawan H, Koh LP, Chao NJ. Rizzieri DA, et al. Among authors: vredenburgh jj. Biol Blood Marrow Transplant. 2003 Mar;9(3):183-8. doi: 10.1053/bbmt.2003.50011. Biol Blood Marrow Transplant. 2003. PMID: 12652469 Free article. Clinical Trial.
Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B.
Marks LB, Halperin EC, Prosnitz LR, Ross M, Vredenburgh JJ, Rosner GL, Peters W. Marks LB, et al. Among authors: vredenburgh jj. Int J Radiat Oncol Biol Phys. 1992;23(5):1021-6. doi: 10.1016/0360-3016(92)90908-z. Int J Radiat Oncol Biol Phys. 1992. PMID: 1639635
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies.
Hussein AM, Petros WP, Ross M, Vredenburgh JJ, Affrontil ML, Jones RB, Shpall EJ, Rubin P, Elkordy M, Gilbert C, Gupton C, Egorin MJ, Soper J, Berchuck A, Clarke-Person D, Berry DA, Peters WP. Hussein AM, et al. Among authors: vredenburgh jj. Cancer Chemother Pharmacol. 1996;37(6):561-8. doi: 10.1007/s002800050429. Cancer Chemother Pharmacol. 1996. PMID: 8612310 Clinical Trial.
169 results